Do all patients with rheumatic Diseases have a higher risk of COVID 19? Initial results from the Karnataka Rheumatology Association COVID 19 Cohort Study (KRACC)-Reference-Cited by-同舟云学术

Do all patients with rheumatic Diseases have a higher risk of COVID 19? Initial results from the Karnataka Rheumatology Association COVID 19 Cohort Study (KRACC)

Published:2021 Issue:2 Volume:16 Page:164
ISSN:0973-3698
Container-title:Indian Journal of Rheumatology
language:en
Short-container-title:Indian J Rheumatol

Author:

Shobha Vineeta,Chanakya K,Haridas Vikram,Kumar Sharath,Chebbi Pramod,Pinto Benzeeta,Jain Vikramraj,Ramaswamy Subramaniam,Prasad Shiv,Patil Abhishek,Rao VijayK,Yathish GC,Dharmanand BG,Jois Ramesh,Kamath Ashwini,Dharmapalaiah Chethana,Sangeeta KN,Janardana Ramya,Srinivasa C,Harshini AS,Srinivasulu Nagaraj,Singh YogeshPreet,Singhai Shweta,Mahendranath KM,Chandrashekara S

Publisher

Medknow

Subject

Rheumatology

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Occurrence and outcome of COVID-19 in AIRD patients on concomitant treatment with Tofacitinib- results from KRA COVID COHORT (KRACC) subset;BMC Rheumatology;2023-07-26

2. Risk factors associated with COVID-19 in systemic lupus erythematosus: Results from a longitudinal prospective cohort;Lupus;2023-02-02

3. Predictors of COVID-19 severity and outcomes in Indian patients with rheumatic diseases: a prospective cohort study;Rheumatology Advances in Practice;2022-12-30

4. Interplay of diabetes mellitus and rheumatic diseases amidst the COVID-19 pandemic: influence on the risk of infection, outcomes, and immune responses;Clinical Rheumatology;2022-09-09

5. A prospective longitudinal study evaluating the influence of immunosuppressives and other factors on COVID-19 in autoimmune rheumatic diseases;BMC Rheumatology;2022-06-14